Jasper Therapeutics prices $50M underwritten offering of 3.9M shares at $12.95/share

Jasper Therapeutics, Inc.

Gross proceeds ~$50M from 3,900,000 shares of common stock at $12.95 per share.
Net proceeds to fund clinical development of briquilimab in mast-cell diseases (CSU, CIndU) and general corporate purposes.
Offering expected to close on or about Feb 8, 2024; underwriters include TD Cowen and Evercore ISI.
Directors and executive officers subject to 90-day lock-up expiring May 7, 2024.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

Jasper Therapeutics, Inc. entered into Underwriting Agreement with Cowen and Company, LLC and Evercore Group L.L.C. valued at Underwritten offering of 3,900,000 shares of voting common stock at $12.95 per share; gross proceeds (effective 2024-02-06).

Action: entry
Agreement: underwriting
Counterparty: Cowen and Company, LLC and Evercore Group L.L.C.
Value: Underwritten offering of 3,900,000 shares of voting common stock at $12.95 per share; gross proceeds
Effective: 2024-02-06

Exact text from the filing

On February 6, 2024, Jasper Therapeutics, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Cowen and Company, LLC and Evercore Group L.L.C., as the representatives of the several underwriters named therein (the “Underwriters”), relating to an underwritten offering (the “Offering”) of 3,900,000 shares of the Company’s voting common stock (“Common Stock”).

View on SEC.gov

119 material agreements filed in the last 30 days. Browse all material agreements →

Jasper Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-24-010267

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.